Skip to main content
OpenTrials

Clinical trial condition

Respiratory Syncytial Viruses

Explore clinical trials studying Respiratory Syncytial Viruses. Study availability and eligibility vary by location and protocol.

13 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Syncytial Viruses trial results

Completed

A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older

NCT04908683

Conditions
Lower Respiratory Tract Disease, Respiratory Syncytial Viruses
Locations
  • Central Research Associates, Inc. Birmingham, Alabama, United States
  • Synexus Clinical Research US Inc Birmingham, Alabama, United States
  • Achieve Clinical Research, LLC Birmingham, Alabama, United States
  • Optimal Research Huntsville, Alabama, United States
View all 272 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age

NCT03303625

Conditions
Infections, Respiratory Syncytial Viruses, Respiratory Tract Diseases, +1 more
Locations
  • Heartland Research Associates, LLC Newton, Kansas, United States
  • Järvenpään rokotetutkimusklinikka Jarvenpaa, Finland
  • University of Tampere/Vaccine Research Center Tampere, Finland
  • University of Tampere/Vaccine Research Center Turku, Finland
View Trial Details
Completed

A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

NCT05966090

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • GSK Investigational Site Daphne, Alabama, United States
  • GSK Investigational Site Tempe, Arizona, United States
  • GSK Investigational Site Corte Madera, California, United States
  • GSK Investigational Site Aurora, Colorado, United States
View all 31 locations
View Trial Details
Completed

A Two-Part Infant Study for Early Diagnosis of Respiratory Syncytial Virus (RSV) and Evaluation of JNJ-53718678 in RSV Acute Respiratory Tract Disease

NCT04068792

Conditions
Respiratory Syncytial Viruses
Locations
  • Instituto de Maternidad y Ginecología Nuestra Senora de las Mercedes San Miguel de Tucumán, Argentina
  • UZ Antwerpen Edegem, Belgium
  • Cevaxin 24 de diciembre Panama City, Panama
  • Cevaxin Avenida Mexico Panama City, Panama
View Trial Details
Completed

Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults

NCT03026348

Conditions
Respiratory Syncytial Viruses
Locations
  • Research Site AU004 Sydney, New South Wales, Australia
  • Research Site AU005 Herston, Queensland, Australia
  • Research Site AU002 Adelaide, South Australia, Australia
  • Research Site AU006 Prahran, Victoria, Australia
View Trial Details
Completed

The Respiratory Protection Effectiveness Clinical Trial

NCT01249625

Conditions
Coronaviridae Infections, Coronavirus, Coronavirus Infections, +13 more
Locations
  • Children's Hospital Colorado Infectious Disease Aurora, Colorado, United States
  • Denver Health Medical Center Denver, Colorado, United States
  • Denver Veteran's Administration Medical Center Denver, Colorado, United States
  • Veterans Affairs Medical Center, Washington, DC Washington D.C., District of Columbia, United States
View Trial Details

Related conditions